Related by context. All words. (Click for frequent words.) 81 BRCA 77 BRCA2 77 BRCA1 gene 70 BRCA mutations 70 BRCA mutation 68 BRCA1 mutations 68 mutated BRCA1 67 BRCA2 mutations 67 BRCA2 gene 66 BRCA2 mutation 66 BRCA genes 65 genes BRCA1 64 BRCA1 mutation 64 PALB2 64 breast cancer genes BRCA1 64 gene mutation 63 gene mutations 63 mutated gene 63 BRCA gene mutation 63 mutation 62 HNPCC 62 breast cancer gene mutation 62 BRCA gene 61 BRCA2 carriers 61 aneuploidy 61 BRCA2 mutation carriers 61 mutations 61 MSH2 61 estrogen receptor 60 BRCA2 breast cancer 60 ApoE4 60 BRCA2 gene mutations 60 HER2 60 atypia 59 BRCA2 gene mutation 59 ApoE4 gene 59 inherited mutations 59 chromosomal abnormalities 59 APOE 59 PTPN# 59 breast cancers 59 atypical hyperplasia 58 APOE e4 58 cyclin D1 58 APOE4 58 ovarian cancers 58 hereditary breast cancer 58 gene variant 58 tumor suppressor gene 58 G#S mutation 58 genetic variant 58 BRCA gene mutations 58 EGFR 57 allele 57 alleles 57 genetic mutations 57 TCF#L# gene 57 TACI mutations 57 LQTS 56 oophorectomy 56 ERBB2 56 MLH1 56 gene variants 56 FGFR2 56 BARD1 56 APOE gene 56 mtDNA mutations 56 CYP#C# [001] 56 CDH1 56 polymorphism 56 TCF#L# 56 genetic mutation 56 CHEK2 56 apolipoprotein E 56 BRAC2 56 autoantibodies 56 genetic abnormalities 56 CYP#D# 56 genetic variants 55 BRAF gene 55 BRCA1 BRCA2 55 MSH6 55 MTHFR gene 55 miRNAs 55 p# protein 55 MTHFR 55 familial pancreatic cancer 55 KRAS mutations 55 ERCC1 55 BRIP1 55 WT1 55 gene 55 TMEM#B 55 germline mutations 55 methylation 55 p# mutations 55 colorectal cancer CRC 55 SNPs 55 heterozygous 55 p# gene 55 TP# mutations 55 endometrial cancers 55 estrogen receptor ER 55 gene BRCA2 55 BRCA1 mutation carriers 55 HOTAIR 55 HER2 gene 55 CDKN2A 55 prostate cancers 55 EGFR gene 55 PIK3CA 55 rs# [002] 54 mutant gene 54 mutated genes 54 noncarriers 54 EGFR mutation 54 Li Fraumeni 54 CNVs 54 CYP#C# * 54 defective gene 54 Clusterin 54 colon cancers 54 PTEN gene 54 lobular carcinoma 54 HER2 receptor 54 familial ALS 54 Fragile X gene 54 estrogen receptor negative 54 BRCA1 gene mutation 54 ApoE4 allele 54 somatic mutations 54 lung adenocarcinoma 54 prophylactic mastectomy 54 latent TB 54 HLA B 54 GSTP1 54 ApoE 54 HPV 54 homozygous 54 TGFBR1 * 6A 54 estrogen receptor alpha 54 PCa 54 prostate specific 54 colorectal neoplasia 53 MDM2 53 polymorphisms 53 variant allele 53 hypermethylation 53 colorectal cancers 53 CYP#D# gene 53 microRNAs 53 genes 53 IDH1 53 MLL2 53 FLT3 53 SORL1 53 p# [001] 53 chromosomal rearrangement 53 invasive breast cancer 53 NF1 53 colorectal cancer 53 anaplastic lymphoma kinase 53 Her2 53 HPV# 53 #q# [001] 53 micro RNAs 53 FOXP3 53 tumor suppressor genes 53 postmenopausal breast cancer 53 genes BRCA 53 STAT3 53 breast tumors 53 K ras mutations 53 single nucleotide polymorphism 53 X chromosome 53 ovarian cancer 53 IgA deficiency 53 GNAQ 53 microdeletions 53 epigenetic 53 PTEN mutation 53 C#Y 53 tumor suppressor 53 V Leiden 53 clusterin 53 Stat5 52 genetic defects 52 NF kB 52 chromosomal aberrations 52 adenoma 52 thyroglobulin 52 uterine ovarian 52 NFkB 52 mutant alleles 52 testicular germ cell 52 ovarian tumors 52 trisomy 52 mosaicism 52 EGFR mutations 52 CFTR gene 52 ovaries removed 52 LRP5 52 vimentin 52 apolipoprotein E gene 52 hormone receptor positive 52 rs# [003] 52 advanced adenoma 52 contralateral breast cancer 52 KRAS mutation 52 chromosomal 52 BRAF mutation 52 Ashkenazi Jewish 52 VKORC1 52 breast cancer metastasis 52 BRCA testing 52 Src 52 CaP 52 prenatal diagnosis 52 advanced adenomas 52 LRRK2 gene 52 KRAS oncogene 52 activating mutations 52 MYH9 gene 52 preeclampsia 52 ε4 52 EGFR protein 52 ABCB1 52 APOL1 52 Foxp3 52 HER2 overexpression 52 sporadic ALS 52 FMR1 gene 52 haplotype 52 ovarian 52 genotype 52 KIF6 gene 52 FTO gene 52 TSC1 52 susceptibility gene 52 human leukocyte antigen 52 COX2 52 mutated BRCA 52 BCR ABL 52 specific antigen 52 breast carcinomas 52 endometrial cancer 52 p# mutation 52 oncogenic 52 KRAS gene 52 linkage disequilibrium 52 haplotypes 52 APOE e4 gene 52 TP# mutation 52 VIPR2 52 IKZF1 52 Wwox 52 BMP2 52 DCIS 51 penetrance 51 salpingo oophorectomy 51 DISC1 51 FXTAS 51 SPINK1 51 tumorigenesis 51 estrogen receptors 51 CDK4 51 germline mutation 51 BRCA mutation carriers 51 breast carcinoma 51 IL#R 51 homozygotes 51 DNA methylation 51 germline 51 FGFR1 51 #q# [002] 51 gene variation 51 CGG repeats 51 MnSOD 51 factor receptor 51 CCR5 delta# 51 gestational diabetes mellitus 51 caveolin 1 51 5 HTTLPR 51 TGF beta 51 variant alleles 51 tumor suppressor protein 51 STAT4 51 tyrosine phosphorylation 51 APOE4 gene 51 MetS 51 RUNX3 51 MC1R 51 Hedgehog pathway 51 KRAS 51 familial adenomatous polyposis 51 APOE allele 51 RBP4 51 polycystic ovary syndrome 51 uPAR 51 mtDNA 51 beta catenin 51 ErbB2 51 JAK2 51 BRAF mutations 51 TAp# 51 nestin 51 hormone therapy estrogen 51 gene amplification 51 shorter telomeres 51 pancreatic cancers 51 malignant transformation 51 FGFR2 gene 51 polycystic ovary syndrome PCOS 51 androgen receptor 51 mutant allele 51 kinases 51 promoter hypermethylation 51 EZH2 51 aromatase 51 maternally inherited 51 K ras 51 BRCA carriers 51 promoter methylation 51 cyclin E 50 HER2/neu 50 GSTM1 50 cystatin C 50 CYP#C# [002] 50 poorer prognosis 50 kinase 50 Pin1 50 MIF protein 50 APOE ε4 50 overexpression 50 TOMM# 50 FANCD2 50 premature ovarian 50 ApoE gene 50 MMP9 50 antigen PSA 50 SMN1 gene 50 HbF 50 E cadherin 50 chlamydial infection 50 genetic disorders 50 oncogene 50 HPV infection 50 Stat3 50 PSA velocity 50 premenopausal 50 malignant lesions 50 genetic abnormality 50 transcription factor 50 estrogen receptor positive 50 HGPIN 50 LKB1 50 amniocentesis 50 PTEN mutations 50 genetic variations 50 microsatellite instability 50 TP# gene 50 oncogenes 50 CNTNAP2 50 micrometastases 50 epithelial ovarian cancer 50 #q#.# [001] 50 HBsAg 50 ALK mutations 50 mitochondrial DNA mtDNA 50 proto oncogene 50 TGF β 50 breast cancer 50 GPC5 50 mRNAs 50 faulty BRCA1 gene 50 NAFLD 50 apoE 50 uterine cancers 50 adenomatous polyps 50 IDH2 50 adenocarcinomas 50 SOD1 gene 50 deleterious mutation 50 genetic 50 elevated CRP 50 adenomas 50 ADAM# 50 epigenetic changes 50 micro RNA 50 genetic polymorphisms 50 miRNA 50 genetic variation 50 imprinted genes 50 SHBG 50 GISTs 50 mRNA expression 50 HMGA2 50 Akt 50 familial hypercholesterolemia 50 abnormal mammogram 50 colorectal tumors 50 K ras gene 50 pancreatic adenocarcinoma 50 endometrial 50 mitochondrial DNA 50 chromosome 50 IDH1 mutation 50 mitochondrial fusion 50 breast cancer recurrence 50 telomere length 50 microcephalin 50 BRAF V#E mutation 50 estrogen receptor beta 50 neuroblastomas 50 FGFR3 49 gestational diabetes 49 AGTR1 49 CIN2 + 49 thyroid cancers 49 Skp2 49 FMR1 49 serotonin transporter gene 49 tamoxifen 49 NF1 gene 49 MGMT gene 49 colorectal carcinoma 49 GSTT1 49 colon tumors 49 palladin 49 Epidermal Growth Factor Receptor 49 prostate cancer CaP 49 advanced neoplasia 49 tumor suppressors 49 chromosomal rearrangements 49 estrogen 49 aneuploidies 49 genomic alterations 49 TOP2A 49 protein kinases 49 subclinical hyperthyroidism 49 progranulin 49 TCF4 49 receptor tyrosine kinase 49 allelic 49 SMN2 49 situ LCIS 49 MGUS 49 HER2 protein 49 LDL receptor 49 protein encoded 49 neurexin 49 exons 49 NKX2 49 PI3K pathway 49 lipoprotein 49 breast ovarian 49 lymph node metastases 49 rs# [001] 49 KIF6 49 poly ADP ribose polymerase 49 tumor recurrence 49 TLR3 49 IGF 1R 49 JAK2 gene 49 MYCN amplification 49 constitutively 49 bladder cancers 49 R#W [002] 49 estrogen receptor progesterone receptor 49 nonmelanoma skin cancers 49 Li Fraumeni syndrome 49 LRRK2 49 faulty BRCA2 gene 49 genomic instability 49 loci 49 MHC molecules 49 invasive carcinoma 49 microRNA 49 JAK2 mutation 49 Hashimoto thyroiditis 49 sarcosine 49 benign lesions 49 homozygosity 49 HLA B# 49 varicocele 49 isoform 49 Peutz Jeghers syndrome 49 miR #a [001] 49 missense mutations 49 NFKBIA 49 ductal cancer 49 gallstone disease 49 sFlt 1 49 bilateral oophorectomy 49 nonsense mutations 49 LRAT 49 HBV 49 serous ovarian cancer 49 G allele 49 BCL#A 49 Rb gene 49 nonsense mutation 49 hereditary hemochromatosis 49 cell adhesion molecule 49 ALK gene 49 benign breast 49 caveolin 49 de novo mutations 49 c Myb 49 Cowden syndrome 49 medulloblastomas 49 PTEN 49 LRP6 48 atypical ductal hyperplasia 48 microdeletion 48 herpesviruses 48 chromosomal defects 48 ataxin 48 recessive mutations 48 genetic defect 48 prostate adenocarcinoma 48 pre menopausal 48 H. pylori 48 SORL1 gene 48 progerin 48 laminin 48 medulloblastoma 48 bone resorption 48 UGT#A# 48 metastatic cancer 48 heterozygosity 48 oncoprotein 48 chromosome abnormalities 48 MicroRNA 48 APOC3 48 chromosomal instability 48 telomere lengths 48 CAG repeats 48 HMGA2 gene 48 lobular breast cancer 48 CagA 48 BRAF V#E 48 premenopausal breast cancer 48 neoplastic 48 Wnt signaling 48 K#N 48 Akt1 48 spontaneous preterm delivery 48 mammary cells 48 primary ovarian insufficiency 48 apoE4 48 allele frequencies 48 TERT 48 pCR 48 overexpressed 48 HNSCC 48 operable breast cancer 48 LIS1 48 E#F# 48 IGFBP 48 c Myc 48 SCN5A 48 coding genes 48 non coding RNAs 48 Heterozygous 48 neurofibromatosis type 48 Sox9 48 c myc 48 NF kB pathway 48 sortilin 48 CETP VV 48 GLI1 48 Myc 48 hereditary breast 48 TSP1 48 epigenetically 48 androgens 48 immunohistochemistry 48 microRNA miR 48 RANKL 48 rs# [004] 48 HER2 negative 48 premature menopause 48 gene expression 48 colorectal carcinomas 48 TOP2A gene 48 HFE gene 48 GSTM1 gene 48 subclinical hypothyroidism 48 microalbuminuria 48 breast cancer susceptibility genes 48 Pten 48 HER2 expression 48 miRNA genes 48 SMN1 48 Her2/neu 48 NR#A# 48 #p# [001] 48 ZNF# 48 lobular cancer 48 virulence genes 48 NPM1 48 axillary lymph nodes 48 adjuvant chemotherapy 48 HER3 48 APOE genotype 48 apoC III 48 renal cell carcinomas 48 SE alleles 48 DNA methylation patterns 48 alternatively spliced 48 mRNA 48 MECP2 gene 48 Ashkenazi Jews 48 susceptibility genes 48 2 diabetes T2D 48 PDGFR 48 epigenetic mechanisms 48 breast cancer subtypes 48 heterozygotes 48 mutated K ras 48 PKD1 48 genetic markers 48 platelet reactivity 48 overexpress 48 thrombophilia 48 Six3 48 preterm delivery 48 recurrent ovarian cancer 48 missense mutation 48 X inactivation 48 CC genotype 48 miR 48 Tamoxifen 48 CCL#L# 48 NF2 48 Neuregulin 1 48 IKKa 48 colorectal polyps 48 tumors 48 Metastases 48 UGT#A# * 48 poor metabolizers 48 mammary cancers 48 PARP inhibition 48 IL 1beta 48 regulator CFTR gene 48 ER alpha 48 lymph node metastasis 48 NRG1 48 colorectal adenomas 48 VHL gene 48 Ovary removal 48 DRD4 48 metastatic disease 48 malignant prostate 48 beta1 integrin 48 autoantibody 48 TG2 48 Alu elements 48 HER-2/neu 48 ADRB2 48 alpha synuclein gene 48 contralateral breast 48 claudin 48 papillary RCC 48 basal cell nevus syndrome 47 metabolic syndrome 47 Notch pathway 47 KIF6 gene variant 47 pharmacogenetic 47 neuroblastoma tumors 47 apolipoprotein E4 47 transthyretin 47 Pap test 47 ductal carcinoma 47 ADPKD 47 mitochondrial 47 invasive ductal 47 mitochondrial metabolism 47 Amniocentesis 47 caspase 47 epidermal growth 47 axillary node dissection 47 MLL gene 47 intestinal polyps 47 endometrial carcinoma 47 p#INK#a 47 Raf MEK ERK 47 telomerase 47 gene fusions 47 ALCL 47 noncoding 47 CXCL# 47 KLF# 47 presenilin 47 telomere dysfunction 47 transcription factors 47 EUS FNA 47 abnormal methylation 47 karyotype 47 PICALM 47 proband 47 Cyclin D1 47 systemic lupus erythematosus SLE 47 eotaxin 47 placental function 47 histone deacetylases 47 tyrosine kinases 47 RAR beta 47 deacetylation 47 Mitochondrial DNA 47 preimplantation genetic diagnosis 47 SGK1 47 lymphomas 47 intron 47 HER2 receptors 47 gene transcription 47 GPx 47 calcineurin 47 HGPS 47 colon polyps 47 KLF4 47 CYP# [002] 47 genotypes 47 gene p# 47 ependymomas 47 HER2 positive 47 preventive mastectomies 47 Breast Cancer Risk 47 sentinel node 47 SLC#A# [001] 47 KRAS wild 47 galectin 3 47 activating mutation 47 G6PD 47 HLA DQ2 47 VEGF receptor 47 thymosin 47 miR #a [002] 47 chromosomal regions 47 narcolepsy cataplexy 47 genes CYP#C# 47 causal variants 47 epigenetic modification 47 recurrent miscarriages 47 NGAL 47 spontaneous mutations 47 metastasis 47 cytokeratin 47 nonmelanoma skin cancer 47 TYMS 47 parkin gene 47 microRNA molecules 47 EGFR receptor 47 FMRP protein 47 adjuvant radiation 47 #p# [003] 47 MEK1 47 beta catenin protein 47 autosomal recessive 47 SHANK3 47 tumor progression 47 PTEN protein 47 SATB1 47 CHD7 47 HPV infections 47 OPRM1 gene 47 ccRCC 47 GRP# 47 NF κB 47 KIT mutations 47 K#R [002] 47 prostate pancreatic 47 DQB1 * 47 gene polymorphisms 47 genes encoding 47 Notch signaling 47 ORMDL3 47 HLA genes 47 anovulatory infertility 47 chromosome #q# [001] 47 BRAF protein 47 GBV C 47 ubiquitylation 47 folate metabolism 47 protein kinase C 47 haematopoietic 47 chromosomes 47 TRAF1 C5 47 progesterone receptor 47 faulty BRCA genes 47 cystic fibrosis transmembrane conductance 47 T#I [002] 47 hTERT 47 asymptomatic 47 Fatty Liver Disease 47 alpha synuclein 47 genetic polymorphism 47 normal karyotype 47 immunohistochemical 47 methylated 47 HPV types 47 CNTNAP2 gene 47 casein kinase 47 Epstein Barr virus EBV 47 PARP inhibitors 47 FTLD 47 CXCR4 47 diagnosis PGD 47 genotyped 47 Chromosome 47 evolutionarily conserved 47 aneuploid 47 protein p# 47 Epstein Barr virus 47 genotoxic stress 47 heterotaxy 47 follicle stimulating hormone FSH 47 c KIT 47 PDE#A 47 dopamine receptor gene 47 ovarian hyperstimulation 47 mucinous 47 HER2 positive cancers 47 RASSF1A 47 neuroligins 47 distant metastases 47 ASCUS 47 TT genotype 47 FOXP3 gene 47 thrombospondin 47 PALB2 gene 47 Meckel Gruber 47 X chromosomes 47 chromosomal disorders 47 diabetes mellitus DM 47 metastases 47 Adjuvant chemotherapy 47 extracolonic findings 47 COMT 47 HER2 positive breast cancer 47 leptin 47 genetic syndromes 47 SOD1 47 HER2 positive tumors 47 abnormal glucose tolerance 47 prediabetes 47 adenocarcinoma 47 prolactin 47 pheochromocytomas 47 premutation 47 lymph node biopsies 47 gene rearrangements 47 melanoma tumors 47 MC1R gene 47 hormonal therapy 47 transferrin saturation 47 Mutational 47 homodimers 47 genes predisposing 47 cause cardiac channelopathies 47 HER2 neu 47 KCNE2 47 tumor antigen 46 c MYC 46 inherited predisposition 46 Wnt#b 46 anal cancers 46 lymphocyte 46 cervical carcinoma 46 methylenetetrahydrofolate reductase 46 fetuin 46 H#K# methylation 46 cancers 46 blastomeres 46 dopamine D4 receptor 46 piRNAs 46 microRNA expression 46 OGG1 46 Recurrence Score 46 NKX#.# 46 pre eclampsia 46 Aneuploidy 46 hedgehog pathway 46 Single Nucleotide Polymorphisms 46 genomic rearrangement 46 CMV infection 46 sCJD 46 endogenous estrogen 46 thyroid nodules 46 cardiac channelopathies 46 CIN2 46 KIAA# 46 GPR# [002] 46 thalassemia trait 46 coronary artery calcium 46 lobular carcinomas 46 papillary thyroid cancer 46 sarcomatoid 46 insulin resistance 46 neural tube defect 46 Cytogenetic 46 endostatin 46 benign growths 46 malignancy 46 SOX9 46 pRb 46 Notch1 46 RPE# 46 miR #b [001] 46 SMAD4 46 Framingham Offspring Study 46 GIST tumors 46 NFAT 46 abnormal mammograms 46 NNRTI resistance 46 leptin receptor 46 Squamous 46 precancer 46 Smad7 46 IL# [001] 46 androgen receptor AR 46 medullary thyroid cancer 46 paternally inherited 46 FSGS 46 NSCLC tumors 46 mutant protein 46 microRNAs miRNAs 46 osteopenia 46 frequently benign tumor 46 selective inhibitors 46 EGFRvIII 46 haptoglobin 46 LRRK2 mutation 46 mitochondrial dysfunction 46 antisense RNA 46 spontaneous preterm birth 46 carcinoembryonic antigen 46 IGF2 46 precursor lesions 46 TGF ß 46 estrogen progesterone 46 #p#.# [001] 46 Fanconi anemia 46 proteinuria 46 ductal breast cancer 46 K RAS 46 #q# deletion 46 Klinefelter syndrome 46 GM CSF 46 pre cancerous polyps 46 genetic alteration 46 tumor cells 46 K ras mutation 46 mammographic density 46 UTRs 46 Y chromosome 46 seminoma 46 T1DM 46 CCR3 46 Chromosomal 46 HG PIN 46 ovarian carcinoma 46 folate intake 46 matrix metalloproteinase 46 thyroid hormone levels 46 perilipin 46 mitochondrial mutations 46 genetic susceptibility 46 IRF6 46 mammary tumors 46 aneuploidy screening 46 tumor suppressing 46 Immunohistochemical analysis 46 H2AX 46 breast epithelial cells 46 carcinomas 46 breast lesions 46 prostate cancer 46 TRIM5 46 Barrett esophagus 46 Mcl 1 46 precancerous polyps 46 pre mRNA splicing 46 IGF IR 46 PPAR alpha 46 KCNQ1 46 microvascular disease 46 UGT#B# 46 Smad3 46 deCODE BreastCancer TM 46 gliomas 46 trastuzumab 46 AAT deficiency 46 Wnt 46 prostate tumor 46 toxoplasmosis 46 breast cancer gene mutations